Melanotan-II Lyophilized Powder – HPLC Verified

Traceable Analytical Data — Every batch of Melanotan-II ships with a certificate stating the exact HPLC conditions, column type, and detection wavelength used for that lot.

Product Specification

Intended Use

Supplied as a raw material for research and manufacturing use. Not for human or veterinary use. Not a finished product.

Why Two Labs Report Different Purity on the Same Melanotan-II Batch

Discrepancies almost always trace back to HPLC method differences, not to the material itself.

I recall a shipment of beauty peptides that went out with >99% purity on the COA, yet the receiving lab measured 0.8 points lower using their own gradient profile. The root cause was a mismatch in column chemistry and detection wavelength — not a material defect. This kind of dispute is common when the Melanotan-II purity HPLC analytical verification report omits method detail. Buyers need the full chromatographic conditions documented per batch to ensure alignment between supplier QC and in-house testing. [NEED_CITE: HPLC method validation requirements per ICH guidelines]

Chromatographic Method Transparency for Melanotan-II Purity HPLC Analytical Verification

Every certificate of analysis for this material names the specific reverse-phase HPLC column, the mobile phase gradient, and the 214 nm UV detection wavelength applied during testing. This level of detail allows receiving laboratories to reproduce the analytical conditions without guesswork. When both sides run the same method, purity results converge within the expected tolerance range, eliminating most disputes before they start.

Mass Spectrometry Identity Confirmation

Beyond chromatographic purity, each batch undergoes mass spectrometry to confirm molecular identity. The MS data verifies that the synthesized peptide matches the expected sequence and molecular weight. Triple verification — HPLC purity, MS identity, and impurity profiling — provides a complete analytical picture. This documentation is critical for QC managers who must demonstrate traceability during audits or regulatory reviews. [NEED_CITE: analytical documentation standards for peptide raw materials]

Interpreting the Specification Parameters

The stated purity of >99% by HPLC is meaningful only when the analytical method is specified; without it, a receiving lab using a different column or gradient may observe variance. The impurity level below 0.1% reflects comprehensive profiling of related substances, which matters for downstream formulation work where trace impurities can interfere with stability studies. Storage at -20°C in sealed, light-protected containers preserves the lyophilized state and prevents hydrolytic degradation. Reconstitution in sterile water or buffer to 1–10 mg/mL, followed by storage at -20°C, extends solution stability to approximately six months — whereas keeping reconstituted material at 4°C limits stability to roughly one month. These parameters directly affect how laboratories plan aliquoting and experimental timelines.

The Hidden Cost of Incomplete Analytical Documentation

When a certificate of analysis lacks method detail, receiving laboratories cannot determine whether a purity discrepancy stems from the material or from analytical conditions. This uncertainty triggers repeat testing, extended hold times, and sometimes full batch rejection — all of which delay research schedules and increase procurement costs. Similarly, if the batch number on the COA does not match the physical vial label, the entire shipment may be flagged during incoming inspection. Method alignment and document consistency are not administrative details; they are the foundation of reliable supply chains. [NEED_CITE: common causes of raw material rejection at QC receiving]

Why Procurement Teams Source This Material Here

Every shipment includes a batch-specific COA that states the exact HPLC method, MS confirmation, and impurity profile for that lot. Custom synthesis is available to buyer-supplied sequences, with feasibility reviews and specification agreements completed before production begins. Research quantities and bulk orders ship from the same facility, ensuring consistency across scale. Temperature-controlled packing with transit records protects the lyophilized powder throughout the cold chain. Import documentation is prepared according to destination-country requirements, reducing the risk of customs delays. Retained samples from each batch support repeat-testing and dispute resolution long after delivery.

Documentation & Traceability

• Batch-specific COA naming the HPLC column, gradient, and 214 nm detection wavelength
• Mass spectrometry report confirming molecular weight identity for each lot
• Impurity profile listing related substances detected during analytical testing
• Safety data sheet reflecting current GHS classification for Melanotan-II
• Certificate of origin and HS code 29371290 for international customs clearance
• Retained sample program supporting post-delivery re-testing and method alignment

Storage, Handling & Shipping

• Store lyophilized Melanotan-II at -20°C in sealed, light-protected containers
• Avoid repeated freeze-thaw cycles after reconstitution to maintain stability
• Aliquot reconstituted solution into single-use volumes before freezing at -20°C
• Temperature-controlled packaging with transit monitoring for cold-chain integrity
• Shipped under HS code 29371290 with import documentation matched to destination requirements

Preparing Your Inquiry

When requesting a quotation, provide your target specification, required batch size, and any specific documentation your market requires for import. If your laboratory will perform incoming QC using an in-house HPLC method, share the method parameters so we can assess alignment with our release testing. Indicate whether retained samples or additional stability data are needed for your quality system.

Frequently Asked Questions

Q: Which HPLC conditions are used to determine Melanotan-II purity?
A: Each batch is tested by reverse-phase HPLC with UV detection at 214 nm. The certificate of analysis specifies the column type, mobile phase gradient, and flow rate. We recommend sharing your in-house method parameters before ordering so we can evaluate whether our release conditions align with your receiving laboratory’s testing protocol.

Q: How is batch-to-COA traceability maintained?
A: Every vial carries a unique batch number that corresponds to a specific certificate of analysis. The COA documents the analytical results, method conditions, and testing date for that exact lot. Retained samples are stored under the same conditions and remain available for re-testing if discrepancies arise during incoming inspection.

Q: What happens if our lab’s re-test result differs from the COA?
A: We first compare analytical methods — column chemistry, gradient profile, and detection wavelength — since most discrepancies originate there. If methods align but results still diverge, we retrieve the retained sample and perform a parallel test. This structured approach resolves the majority of purity disputes within a defined timeframe.

Q: What are the storage requirements for lyophilized and reconstituted material?
A: Unopened lyophilized Melanotan-II should be stored at -20°C, sealed and protected from light, with a shelf life of 24 months from manufacturing. After reconstitution in sterile water or buffer, the solution remains stable for approximately one month at 4°C or up to six months when stored at -20°C.

Q: How is batch consistency verified across multiple orders?
A: Each batch undergoes triple verification: HPLC purity testing, mass spectrometry identity confirmation, and impurity profiling. Results are documented on the batch-specific COA. Retained samples and manufacturing records allow us to demonstrate consistency across lots and support ongoing quality audits.